Evidence map›Paper›PMID 17698860›Full record

ArticleGut2007

Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands.

A C de Vries, G A Meijer, C W N Looman, M K Casparie, B E Hansen, N C T van Grieken, E J Kuipers

Open access · bronzeAbstract read
In one paragraph

Article in Gut, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Inflammation and Gastric Cancer.Diseases (Basel, Switzerland) · 2022
    Review
  3. Detection and Treatment ofGastroenterology research and practice · 2022
    Review
  4. Article
  5. The Single-Nucleotide Polymorphism of miR-27aEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  6. Article
  7. HDAC6/HNF4α loop mediated by miR-1 promotes bile acids-induced gastric intestinal metaplasia.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2021
    Article
  8. Observational
  9. Current Perspectives in Atrophic Gastritis.Current gastroenterology reports · 2020
    Review
  10. Observational
  11. Gastric Cancer: an Evolving Disease.Current treatment options in gastroenterology · 2018
    Review
  12. Article
  13. Article
  14. New advances in targeted gastric cancer treatment.World journal of gastroenterology · 2016
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

A C de VriesDepartment of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands. A.C.deVries@erasmusmc.nl
G A Meijer
C W N Looman
M K Casparie
B E Hansen
N C T van Grieken
E J Kuipers
Erasmus MC · NLAmsterdam UMC Location VUmc · NLErasmus University Rotterdam · NLUniversity Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe pre-malignant gastric lesions atrophic gastritis (AG), intestinal metaplasia (IM) and dysplasia (DYS) have long been identified as principal risk factors for gastric cancer.

objectiveTo evaluate epidemiological time trends of pre-malignant gastric lesions in the Netherlands.

methodsPatients with a first diagnosis of AG, IM or DYS between 1991 and 2005 were identified in the Dutch nationwide histopathology registry. The number of new diagnoses per year were evaluated relative to the total number of patients with a first gastric biopsy. Time trends were evaluated with age-period-cohort models using logistic regression analysis.

resultsIn total, 23 278 patients were newly diagnosed with AG, 65 937 patients with IM, and 8517 patients with DYS. The incidence of AG declined similarly in men and women with 8.2% per year [95% CI 7.9% to 8.6%], and DYS with 8.1% per year [95% CI 7.5% to 8.6%]. The proportional number of new IM cases declined with 2.9% per year [95% CI 2.7% to 3.1%] in men and 2.4% [95% CI 2.2% to 2.6%] in women. With age-period-cohort models a cohort phenomenon was demonstrated for all categories of pre-malignant gastric lesions in men and in women with IM and DYS. Period phenomena with a larger decline in number of diagnoses after 1996 were also demonstrated for AG and IM.

conclusionsThe incidence of pre-malignant gastric lesions is declining. Period and cohort phenomena were demonstrated for diagnoses of AG and IM. These findings imply that a further decrease of at least 24% in the incidence of gastric cancer in the coming decade may be anticipated in Western countries without specific intervention.

Indexed as

AdultAgedAged, 80 and overAge DistributionEpidemiologic MethodsFemaleGastric MucosaGastritis, AtrophicHumansMaleMetaplasiaMiddle AgedNetherlandsPrecancerous ConditionsSex DistributionStomach Neoplasms

Identifiers

PMID17698860
PMCPMC2095713
OpenAlexW2096132174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.